Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Atherogenics Inc. (AGIX)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: AGIX
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Analysis - Latest Articles
by
most recent
|
most commented
The Best and Worst Performing Stocks in the U.S.
Apr 24, 2008
•
TickerSense
•
2 Comments
The Next Great Biotech Short Squeeze
Apr 23, 2007
•
Andrew Vaino
•
Comment!
AstraZeneca Terminates Production of AtheroGenics' AGI-1067; Beats Pretax Estimates
Apr 23, 2007
•
SA Editor Jonathan Liss
•
Comment!
Russell 3000's Best and Worst Stocks, Week and Year to Date
Apr 14, 2007
•
TickerSense
•
Comment!
Russell 3000's Best and Worst Stocks, Week and Year to Date
Apr 8, 2007
•
TickerSense
•
Comment!
How To Avoid Investment Landmines
Apr 2, 2007
•
Alan Brochstein
•
Comment!
AtheroGenics' Heart Drug Shows Promise on Secondary Goals
Mar 28, 2007
•
SA Editor Judith Levy
•
Comment!
Biotech Day In Review: Regeneron Up On AMD Data
Mar 28, 2007
•
Comment!
Russell 3000's Best and Worst Stocks, Week and Year to Date
Mar 24, 2007
•
TickerSense
•
Comment!
Biotech Day in Review: AtheroGenics Tumbles on Drug Test Failure
Mar 20, 2007
•
Centient Biotech Investor
•
Comment!
AtheroGenics' Heart Drug Misses Primary Endpoint, Shares Plummet
Mar 19, 2007
•
SA Editor Eli Hoffmann
•
Comment!
AtheroGenics: No Guts, No Glory
Feb 8, 2007
•
John Cramer
•
Comment!
The Short Case On Atherogenics
Feb 1, 2007
•
Maxim Jacobs
•
Comment!
AtheroGenics: The Clock Is Ticking
Jan 30, 2007
•
Anthony Payne
•
Comment!
Biotech Stocks Review: Amphora Sells Oncology Program to Genentech
Jan 10, 2007
•
Centient Biotech Investor
•
Comment!
Alnylam, CytRx Gain by Moving into RNAi
Jan 10, 2007
•
H.S. Ayoub
•
Comment!
Biotech Stocks Day-in-Review: Controversy For Genentech Cancer Drug
Jan 7, 2007
•
Centient Biotech Investor
•
Comment!
Pharma IPO: Highlights from ActivBiotics' S-1 Filing
Aug 23, 2006
•
Evelyn Rubin
•
Comment!
One Page Barron's Summary
May 15, 2006
•
SA Editors
•
Comment!